Vistin Pharma ASA: Mandatory notification of trade

Magnus Tolleshaug, Chief Executive Officer in Vistin Pharma ASA, and a primary insider, has on 20'th of February 2026 purchased 30.000 shares in Vistin Pharma ASA at an average price of NOK 21,10 per share. Following this purchase Magnus Tolleshaug holds 105.000 shares in Vistin Pharma ASA.

Attachment

• Notification of trade_skjema - Magnus Tolleshaug

You May Also Be Interested In

• Tabi Connect Reports Awarded Broker Margins Fell to 16.9% in July as Spot Quote Volume Rose 15%
• TOURISE and Oxford Economics Release New Global Report on Tourism Resilience in an Era of Permanent Disruption
• Jonas Brothers Are Burnin' Up with PopUp Bagels